OVID
Ovid Therapeutics Inc
2.50$
+3.3%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +1,551.6% | -99.3% | -73.9% | +44.4% | +1,181.3% | |
| – | – | +379.8% | +42.1% | +76.5% | +79.9% | – | – | – | +15.6% | -62.4% | -50.0% | |
| – | – | – | – | – | – | – | +1,551.6% | -99.3% | -73.9% | +44.4% | +1,128.3% | |
| – | +6,174.7% | +45.0% | +421.3% | -32.4% | +24.8% | +50.4% | -26.0% | -47.6% | +16.1% | +28.6% | -30.4% | |
| – | +1,826.1% | +96.9% | +16.1% | +27.3% | +0.6% | +59.1% | +21.6% | -12.9% | -8.8% | -13.2% | -6.1% | |
| – | +2,851.5% | +70.9% | +188.5% | -18.6% | +16.0% | +53.1% | -10.5% | -32.2% | +4.6% | +4.7% | -20.9% | |
| – | – | – | – | – | – | – | – | -144.7% | – | – | – | |
| – | – | – | – | – | – | – | – | +5,799.8% | – | – | – | |
| – | – | – | – | – | – | – | – | -143.6% | – | – | – | |
| – | – | – | – | – | -226.4% | – | – | -307.8% | – | – | – | |
| – | – | – | – | – | – | – | – | -141.9% | – | – | – | |
| – | – | – | – | – | – | – | – | -143.5% | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.